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author touches upon issues associated with
“opting-out” of universal coverage to accept
“customized” private services. A detailed
econometrics exercise is then performed to
determinethe impactof“de-listing”services
from a universal health plan. Other issues,
such as the allocation of a doctor’s time for
private vs. public service and the ethics of
private insurance marketing in a universal
healthcare market, are covered as well.
The rest of the chapters focus on con-
sumer directed healthcare (CDHC), medical
savings accounts (MSAs), and economic in-
centives. With complex economic models,
the author argues that high-deductible (HD)
plans result in a stronger “illness preven-
tion” behavior than a conventional plan.The
author also highlights that individuals with
low likelihood of illness are more likely to
choose HD plans. The next chapter high-
lights the introduction of MSAs within the
United States, Singapore, and China, and the
role MSAs would play in public spending
and saving in Canada. The concepts of “de-
mand side incentives” and “supply side in-
centives” are introduced to highlight the role
of patient and provider incentives.The book
expands these concepts to include physician,
health plan, and provider incentives.The au-
thor concludes that health services in
Canada are, for the most part, equally bal-
anced between poor and rich socioeconomic
groups. However, for services not covered
under the universal plan (i.e., dental), there
is strong evidence that supports unequal
coverage among socioeconomic groups, and
despite equal coverage between socioeco-
nomic groups, lower income populations are
in worse health overall than higher income
populations.
A particular strength of this work is its
ease in organization. Each section is clearly
titled and defined, allowing the reader to
scan the book quickly to retrieve informa-
tion of particular interest. The graphs, eco-
nomic charts, and tables are clear and
relevant, adding breadth to the text, which
contains detailed, technical information to
support the economic concepts.
Adownside is the style of writing varies
drastically from chapter to chapter. Some
sections of chapters contain high level exec-
utive summaries that are clear and easy to
read. Other sections dive deep into the un-
derlying economic theory that supports the
health policy, which could challenge any
reader who hasn’t pursued advanced study
in economics and/or mathematics.
Aninterestingsurpriseaboutthiscompi-
lationisitsfocusaroundtheCanadianuniver-
sal healthcare system. The readings gave an
interesting perspective about the potential in-
efficienciesandinequitiesofuniversalcover-
age or the role of non-covered services.
However, I would have liked to have seen
how the economic models discussed in the
chapters on consumer directed healthcare
(CDHC) would impact a privatized, frag-
mented healthcare system such as the United
States. There is also the assumption that the
readeralreadyhasaclearunderstandingofthe
Canadian healthcare system.
Financing Health Care: New Ideas for a
ChangingSocietymaynotcontainallthesolu-
tionsneededtoimproveauniversalhealthcare
system, but it does give strongly supported,
economic frameworks to help the reader gain
adeeperunderstandingofpublicvs.privatefi-
nancing, CDHCs, MSAs, and incentives
among stakeholders in a universal healthcare
system. It is an excellent resource for health
economists and public policy advocates who
wish to support their healthcare reform argu-
mentswithunderlyingeconomictheory,orthe
student who wishes to understand the under-
lying economics behind health reform policy
inauniversalcoveragesystem.Iwould,how-
ever,recommenddustingoffyourfavoritemi-
croeconomics textbook before diving in.
Christopher Edell
Yale School of Management
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Though many chapters in Unnatural
History: Breast Cancer and American Soci-
ety revisit expected material — SusanBook reviews 154
Emlen’s personal account of her surgery for
a breast cancer in 1814, Halsted’s develop-
ment of the radical mastectomy — author
Robert Aronowitz succeeds at combining
these stories with newer ideas about the de-
velopment of breast cancer “risk rhetoric”
into an overall compelling and well-re-
searched narrative about how the medical
establishment dealt with breast cancer as a
diagnosis throughout the last two centuries
and how the public responded.
Oneofthemainpremisesisthat“Amer-
ican women fear breast cancer now more
than the last 100 years.” Undoubtedly —
given the current ubiquity of the “1 in 8” sta-
tistic and the visibility of causes such as the
Race for the Cure — this is true;Aronowitz
takes up the pertinent question why. While
acknowledging the tentative observation of
increasedbreastcancerincidence(andthere-
forevisibility),hemainlyfocusesonhowso-
ciological and cultural aspects of illness and
medicine in the last century have shaped our
ideas about cancer, and breast cancer in par-
ticular. Much of the story lies in the history
of how cancer was understood: Was it con-
sidered a local or a constitutional disease?
Howdidit“travel?”Overwhataspectscould
medicine have an effect? In the chapters de-
tailing the personal experiences of Susan
Emlen (in 1814) and Rachel Carson (in the
1960s),Aronowitz points out striking conti-
nuities in medical care surrounding breast
cancer: For example, in the face of so many
unknowns, medical professionals often
hedged answers to patients in an effort to
communicate a delicate combination of real-
ism and hope, most of the time by withhold-
ing an actual cancer diagnosis.
Toward the end of the book,Aronowitz
delves into his most original material by dis-
secting the “rhetoric of risk” that has come
to dominate our thinking about breast can-
cer. Women, he argues, have been increas-
ingly encouraged to think of themselves as
at risk for breast cancer. In theory, this serves
the purpose of convincing women to get
screened early and regularly, but he argues it
also has promoted a fear of breast cancer
that is if not inappropriate, at least dispro-
portionate to the cause.
The question of fear seems to lie at the
root of his discussion. Aronowitz strikes a
chord in his assessment that our culture dis-
proportionately fears breast cancer and that
this cultural fear ultimately plays out in indi-
vidualwomen’slivestothedetrimentoftheir
overall well-being and decision-making ca-
pabilities,yetitremainsimportanttoexplore
thedynamicsofthatfearinorder tosetus on
the path toward appropriately mitigating it.
Aronowitz’s work does not intend to
capture the entire story; its complexity is
likely beyond the scope of one work any-
way. It is to his credit that he sheds new light
on how we understand breast cancer, and his
focus on “non-biological” aspects of the dis-
ease opens future doors. Overall, the book
provides valuable insight and several reveal-
ing historical gems illuminating how our un-
derstanding of breast cancer has changed
with the times. Fans of history of medicine
(as well as the history of surgery, oncology,
and women’s health) will find many chap-
ters rewarding, and, along with the other
works that begin to deconstruct how we
think about our medical practices in a his-
torical and sociological light, it is an impor-
tant addition to all medical libraries.
Margaret F. Reynolds
Yale University School of Medicine
Culture of Human Stem Cells (Culture
of Specialized Cells). Edited by R. Ian
Freshney, Glyn N. Stacey, and Jonathan
M. Auerbach. Hoboken, New Jersey:
John Wiley & Sons, Inc.; 2007. 343 pp.
US $132.95 Hardcover. ISBN: 978-
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The explosion of interest in human stem
cells over the last decade has led to a rapidly
expanding field that employs a multitude of
techniques to culture and differentiate stem
cells. Mining the primary literature for
methods and protocols needed to derive,
propagate, and characterize embryonic and
adult human stem cells can be a daunting
task for graduate students, clinicians, and
experienced researchers alike. Culture of
Human Stem Cells, edited by R. Ian Fresh-